Cargando…
Efficacy and Safety of Botulinum Toxin Type A in Treating Patients of Advanced Age with Idiopathic Trigeminal Neuralgia
OBJECTIVE: To assess the therapeutic efficacy and safety of botulinum toxin type A (BTX-A) for treating idiopathic trigeminal neuralgia (ITN) in patients ≥80 years old. METHODS: Selected patients (n=43) with ITN, recruited from the neurology clinic and inpatient department of the Second Affiliated H...
Autores principales: | Liu, Jing, Xu, Ying-Ying, Zhang, Qi-Lin, Luo, Wei-Feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5907496/ https://www.ncbi.nlm.nih.gov/pubmed/29849847 http://dx.doi.org/10.1155/2018/7365148 |
Ejemplares similares
-
Therapeutic Efficacy of Botulinum Toxin in Trigeminal Neuralgia
por: Kayani, Abdul Mueez Alam, et al.
Publicado: (2022) -
The Efficacy and Safety of Microvascular Decompression for Idiopathic Trigeminal Neuralgia in Patients Older Than 65 Years
por: Yang, De-bao, et al.
Publicado: (2014) -
Therapeutic efficacy and safety of botulinum toxin type A in trigeminal neuralgia: a systematic review
por: Hu, Yong, et al.
Publicado: (2013) -
Efficacy of Botulinum Toxin Type A in Trigeminal Neuralgia in a South Asian Cohort
por: Caldera, Manjula Chandragomi, et al.
Publicado: (2018) -
Botulinum toxin in the treatment of trigeminal neuralgia: 6-Month follow-up
por: Türk Börü, Ülkü, et al.
Publicado: (2017)